Based on recombinant Factor C (rFC), ENDONEXT™ technology not only eliminates the need to harvest horseshoe crab blood, but also makes your laboratory more efficient. With 100% endotoxin specificity, lot-to-lot consistency, and more streamlined workflows, ENDONEXT™ provides reliable results everywhere from in-process controls to final product testing on the most complex matrices.
Features
- Easy automation with robotic liquid-handling systems
- Fluorescence end-point assays in a 96-well microplate format
Main Benefits
- 100% endotoxin specificity
- High lot-to-lot consistency
- Ecologically sustainable
- Validated according to standard pharmacopoeia Bacteria Endotoxin Testing criteria
VI